SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy to further strengthen growth opportunities for both organizations. “We believe having the cell analysis team as part of DGG is a natural fit given […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ExCellerate™ GMP iPSC Expansion Medium, Animal Free (CCM036-GMP), supporting the development and manufacture of regenerative medicine and stem cell therapies. ExCellerate GMP iPSC Expansion Medium is optimized to support robust expansion and maintenance […]
MicrofluidX secures £1m funding via Innovate UK Investor Partnerships Future Economy programme, supported by Longwall Ventures. Stevenage, UK– MicrofluidX (MFX), a UK-based developer of technologies that streamline the development and deployment of cell and gene therapies, is delighted to announce that it has been awarded £685,000 in funding from Innovate UK via their Investor Partnership […]
WATERTOWN, Mass. — Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are excited to announce their collaboration to enhance the accessibility and scalability of single-cell RNA sequencing (scRNA-seq). Single-cell RNA sequencing has been a crucial tool in unraveling cellular and molecular diversity within complex tissues. […]
CellAssist Software Release 5.0 provides advanced capabilities to accurately count cells and measure their confluence using quantitative phase imaging (QPI) and proprietary algorithms BOSTON — Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities […]
Miltenyi Biotec to supply scalable, GMP-compliant, PRAME-targeted TCR-NK cell therapy product using the CliniMACS Prodigy® system for clinical development and future commercial supply Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 2024 Bergisch […]
NORTH BRUNSWICK, N.J. — TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits. Using the xeno-free VitroGel® hydrogels, these new kits revolutionize how researchers study cell migration and invasion, offering unprecedented accuracy, efficiency, and reliability for cell migration assays. The VitroGel-Based Cell […]
SAN DIEGO — Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL. The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission’s divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024. On December 15, the U.S. […]
Biotech company, Cytomos (www.cytomotos.com) is pleased to announce the creation of its newly named AuraCyt™ cell analysis technology brand and the launch of its enhanced website www.cytomos.com – encapsulating the transformative R&D benefits of its ground-breaking cell analysis technology. AuraCyt™ provides information on AuraCyt™ provides information on cell properties that is set to revolutionise analytical technology (PAT) […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding for an innovation project. The collaboration aims to develop novel AI-based assay development tools for spatial biology on Lunaphore’s COMET™ to further accelerate the adoption of multiplex sequential immunofluorescence (seqIF™) technology in research. Spatial […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
